Volume 22, Number 4—April 2016
Letter
Follow-up of Ebola Patient, 2014–2015
Table
1 | 2 | 3 | 4 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NCDC‡ |
NIV§ |
CPE |
Ct |
CPE |
Ct |
CPE |
Ct |
CPE |
Ct |
||||||
1 |
45 |
17 |
22.5 |
Vero CCL81 | None | 28.5 | None | None | None | None | None | None | |||
Vero E6 |
None |
31.5 |
None |
None |
None |
None |
ND |
None |
|||||||
2 |
64 |
21 |
24 |
Vero CCL81 | None | None | None | None | None | None | ND | ND | |||
Vero E6 |
None |
32.5 |
None |
None |
None |
None |
ND |
ND |
|||||||
3¶ |
77 |
22 |
ND |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|||
4¶ |
98 |
26 |
ND |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|||
5¶ |
111 |
27 |
ND |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|||
6 |
125 |
30 |
34 |
Vero CCL81 | None | None | None | None | ND | ND | ND | ND | |||
Vero E6 |
None |
None |
None |
None |
ND |
ND |
ND |
ND |
|||||||
7 |
141 |
28 |
38 |
Vero CCL81 | None | None | None | None | ND | ND | ND | ND | |||
Vero E6 |
None |
None |
None |
None |
ND |
ND |
ND |
ND |
|||||||
8 | 165 | 28 | 35.0 | Vero CCL81 | None | None | None | None | ND | ND | ND | ND | |||
BHK-21 | None | None | None | None | ND | ND | ND | ND |
*Ct, cycle threshold; CPE, cytopathic effect; NA, not applicable; NCDC, National Centre for Disease Control, New Delhi, India; ND, not done; NIV, National Institute of Virology, Pune, India; RT-PCR, reverse transcription PCR.
†Primers from http://www.crcf.sn/wp-content/uploads/2014/09/CDC-Ebola-International-Lab.pdf.
‡Primers from the Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
§Primers from (7).
¶Samples received at NCDC only.
References
- World Health Organization. Eighth Meeting of the WHO Advisory Group on the EVD Response; 2015 Mar 20; Geneva. Geneva: The Organization; 2015 [cited 2015 Mar 25]. http://www.who.int/csr/disease/ebola/advisory-groups/8th-meeting-report.pdf?ua=1
- World Health Organization. WHO Statement on the Meeting of the International Health Regulations Emergency Committee Regarding the 2014 Ebola Outbreak in West Africa; 2014 Aug 8; Geneva. Geneva: The Organization; 2014 [cited 2014 Nov 3]. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/
- Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Transmission of Ebola viruses: what we know and what we do not know. mBiol. 2015;6 [cited 2016 Jan 19]. http://dx.doi: DOIGoogle Scholar
- Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196(Suppl 2):S142–7. DOIPubMedGoogle Scholar
- Rodriguez LL, De Roo A, Guimard Y, Trappier SG, Sanchez A, Bressler D, Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S170–6. DOIPubMedGoogle Scholar
- ProMEDmail. Ebola virus disease—ex Africa (39): India, worldwide susp. or quarantined. 2014 Nov 18 [cited 2015 Dec 23]. http://www.promedmail.org, archive no. 20141118.2966874.
- Towner JS, Sealy TK, Ksiazek TG, Nichol ST. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis. 2007;196(Suppl 2):S205–12. DOIPubMedGoogle Scholar
- Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel M, Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl 1):S177–87. DOIPubMedGoogle Scholar
- Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol. 2002;40:2323–30. DOIPubMedGoogle Scholar
- O'Dempsey T, Khan SH, Bausch DG. Rethinking the discharge policy for Ebola convalescents in an accelerating epidemic. Am J Trop Med Hyg. 2015;92:238–9. DOIPubMedGoogle Scholar
- Deen GF, Knust B, Broutet N, Sesay FR, Formenty P. Ross C Ebola RNA persistence in semen of Ebola virus disease survivors—preliminary report. N Engl J Med. 2015 Oct 14 [cited 2015 Oct 20]. DOIGoogle Scholar
Page created: March 16, 2016
Page updated: March 16, 2016
Page reviewed: March 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.